Day: August 1, 2024

NEW DELHI, India and REDWOOD CITY, Calif., July 31, 2024 (GLOBE NEWSWIRE) — PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced its association with Disney+ Hotstar, to transform the advertising landscape for digital advertising. Disney+ Hotstar, India’s streaming platform offering a wide range of content across Indian and international titles, has selected PubMatic to enable programmatic monetization of content across multiple buying channels, including audience based and 1:1 private marketplace (PMP) and programmatic guaranteed campaigns. PubMatic’s sell-side technology allows publishers to connect with a broad set of global buyers while allowing them to maintain control over their user experience and maximize revenue yield. “We are thrilled...

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, reports the voting results from its Annual General and Special Meeting of shareholders (the “Meeting”) held earlier today. A total of 40,039,174 shares were represented in person or by proxy at the Meeting, constituting approximately 71% shares represented of the Company’s total issued and outstanding Common shares as of the record date, and voted in favour of all matters brought before the Meeting. Results of Annual General and Special Meeting The following matters put forward before shareholders for consideration and approval as set out in Rubicon Organics’ management information circular...

MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the pricing of its underwritten public offering of 30,434,783 shares of its common stock at an offering price of $1.15 per share of common stock for gross proceeds of $35 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Ocugen. In addition, Ocugen has granted to the underwriter a 30-day option to purchase up to 4,565,217 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about August 2, 2024, subject to the satisfaction of customary closing conditions. Ocugen...